Get the Stockscreener App
182.61
0.03%
0.06
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $182.61, with a volume of 1.06M.
It is up +0.03% in the last 24 hours and up +2.11% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$182.55
Open:
$183.27
24h Volume:
1.06M
Relative Volume:
1.05
Market Cap:
$20.31B
Revenue:
$10.52B
Net Income/Loss:
$999.00M
P/E Ratio:
21.84
EPS:
8.3628
Net Cash Flow:
$1.22B
1W Performance:
-3.73%
1M Performance:
+2.11%
6M Performance:
+5.20%
1Y Performance:
+12.76%
1-Day Range:
$182.21
$184.16
1-Week Range:
$182.21
$190.25
52-Week Range:
$148.70
$197.55
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
182.61 | 20.31B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
580.45 | 218.05B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
228.46 | 160.05B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
725.93 | 58.51B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
149.26 | 42.12B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
227.24 | 38.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Will Quest Diagnostics Incorporated stock outperform benchmarksJuly 2025 Trends & Real-Time Chart Breakout Alerts - Newser
Published on: 2025-12-03 05:06:27 - Newser
Is Quest Diagnostics Incorporated (QDI) stock ideal for retirement investorsPortfolio Performance Report & Daily Volume Surge Signals - Newser
Is Quest Diagnostics Incorporated stock nearing a technical breakoutExit Point & Expert Approved Momentum Ideas - Newser
Is Quest Diagnostics Incorporated stock cheap vs fundamentalsJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
Why analysts maintain buy rating on Quest Diagnostics Incorporated stockBreakout Watch & Low Drawdown Momentum Ideas - Newser
Published on: 2025-12-02 04:36:26 - Newser
How cyclical is Quest Diagnostics Incorporated stock compared to rivals2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - sharewise.com
Quest Diagnostics, Octave Collaborate to Expand Multiple Sclerosis Disease Activity Test Access - MarketScreener
Octave Bio lands massive deal with Quest Diagnostics that will expand reach of its multiple sclerosis tests - The Business Journals
Quest Diagnostics (NYSE: DGX) to offer Octave MSDA MS blood test at 7,000 U.S. sites - Stock Titan
Quest Diagnostics Insider Sold Shares Worth $10,589,760, According to a Recent SEC Filing - MarketScreener
Insider Sell: Vicky Gregg Sells Shares of Quest Diagnostics Inc (DGX) - GuruFocus
Chmn Davis Sells 55,093 ($10.6M) Of Quest Diagnostics Inc [DGX] - TradingView
Dir Gregg Sells 1,250 ($239.7K) Of Quest Diagnostics Inc [DGX] - TradingView
Quest Diagnostics (DGX) CEO James E. Davis exercises options and sells common stock - Stock Titan
[Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity - Stock Titan
Can Quest Diagnostics Incorporated stock deliver sustainable ROEQuarterly Profit Report & AI Driven Stock Price Forecasts - BỘ NỘI VỤ
HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet? - Finviz
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - sharewise.com
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
[144] QUEST DIAGNOSTICS INC SEC Filing - Stock Titan
Dir Gregg Files To Sell 1,250 Of Quest Diagnostics Inc [DGX] - TradingView
Should You Hold Quest Diagnostics Stock in Your Portfolio for Now? - sharewise.com
DGX Stock Up on New Blood Test Development Deal With MD Anderson - MSN
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Is Quest Diagnostics Incorporated (QDI) stock protected from inflationQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
Quest Diagnostics (DGX): A Fresh Look at Valuation After Strong Q3 Earnings and Raised Outlook - Yahoo Finance
How Quest Diagnostics Incorporated stock performs in rate cut cyclesQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Quest Diagnostics (DGX) Up 2.6% Since Last Earnings Report: Can It Continue? - sharewise.com
Quest Diagnostics Executive Sells Shares - TradingView
VP Delaney Sells 7,946 ($1.5M) Of Quest Diagnostics Inc [DGX] - TradingView
Quest Diagnostics Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
How Quest Diagnostics Incorporated stock valuations compare to rivalsQuarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Can Quest Diagnostics Incorporated (QDI) stock deliver strong annual returnsChart Signals & Real-Time Chart Pattern Alerts - newser.com
How Quest Diagnostics Incorporated stock benefits from global expansionTake Profit & Expert Curated Trade Setup Alerts - newser.com
Is Quest Diagnostics Incorporated (QDI) stock good for long term investingPortfolio Growth Summary & Consistent Profit Focused Trading Strategies - newser.com
Will Quest Diagnostics Incorporated stock profit from fiscal stimulus2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Published on: 2025-11-19 23:07:04 - newser.com
Using flow based indicators on Quest Diagnostics IncorporatedJuly 2025 Outlook & Safe Capital Preservation Plans - newser.com
What Fibonacci levels say about Quest Diagnostics Incorporated reboundIPO Watch & Weekly Top Stock Performers List - newser.com
Published on: 2025-11-19 13:33:19 - newser.com
Is Quest Diagnostics Incorporated (QDI) stock positioned for secular growthPrice Action & Advanced Swing Trade Entry Plans - newser.com
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
0.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):